Despite significant efforts, there are currently no approved treatments for COVID-19. However, biotechnological approaches appear to be promising in the treatment of the …
JC Wilson, D Kealy, SR James, T Plowman, K Newling… - IScience, 2022 - cell.com
Inflammatory cytokines and chemokines (CC) drive COVID-19 pathology. Yet, patients with similar circulating CC levels present with different disease severity. Here, we determined …
Pulmonary fibrosis is the key feature of majority of idiopathic interstitial pneumonias (IIPs) as well as many patients with post-COVID-19. The pathogenesis of pulmonary fibrosis is a …
X Lan, H Li, J Guo, C Feng, X Zhou, J Wang, D Li… - Chemical Engineering …, 2024 - Elsevier
The RNA-dependent RNA polymerase (RdRp) of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), known as nsp12, is crucial to viral replication and spread …
After the outbreak of coronavirus disease 2019 (COVID‐19) in December 2019 and the increasing number of SARS‐CoV‐2 infections all over the world, researchers are struggling …
S Stebel, J Breuer, O Rossbach - Methods and Protocols, 2022 - mdpi.com
Transcriptome-wide analysis of RNA-binding partners is commonly achieved using UV crosslinking and immunoprecipitation (CLIP). Individual-nucleotide-resolution CLIP (iCLIP) …
The COVID-19 pandemic caused by the SARS-CoV-2 coronavirus has resulted in numerous deaths in many countries around the world. Vaccination of the population reduces mortality …